Compare JFU & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | JFU | COCH |
|---|---|---|
| Founded | 2006 | 1995 |
| Country | China | United States |
| Employees | N/A | 47 |
| Industry | Finance: Consumer Services | Blank Checks |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.7M | 49.7M |
| IPO Year | 2018 | N/A |
| Metric | JFU | COCH |
|---|---|---|
| Price | $3.08 | $0.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 7.2K | ★ 109.3K |
| Earning Date | 12-09-2022 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.43 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.25 | $0.36 |
| 52 Week High | $9.48 | $1.89 |
| Indicator | JFU | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 41.97 | 53.76 |
| Support Level | $2.65 | $0.63 |
| Resistance Level | $4.79 | $0.74 |
| Average True Range (ATR) | 0.47 | 0.04 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 7.07 | 58.18 |
9F Inc is a digital technology and wealth management service provider aiming to empower institutional partners with financial technologies as well as attract investors with investment opportunities that come with the vast potential of China's new consumer economy and the appreciation of world-wide assets and access to quality products at a competitive price. The Company's operations are organized into segments, consisting of E-commerce services, technology Empowerment service, and Wealth Management services.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.